1-20 of 20
Triparna Sen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 51: Multiomic profiling of patient-derived xenografts established from patients with malignant pleural mesothelioma proposes pathways associated with poor prognosis

Michael Offin, Jennifer L. Sauter, Jacklyn V. Egger, Elisa deStanchina, John T. Poirier, Marjorie G. Zauderer, Charles Rudin, Triparna Sen
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 51.
DOI: https://doi.org/10.1158/1538-7445.AM2022-51
Published: 15 June 2022
View article
Journal Articles

Abstract 1370: Targeting LSD1 rescues MHC-I antigen presentation in small cell lung cancer

Minh N. Nguyen, Hirokazu Taniguchi, Andrew Chow, Yingqian A. Zhan, Triparna Sen, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1370.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1370
Published: 15 June 2022
View article
Journal Articles

Abstract 658: AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation

Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A. Zhan, Fathema Uddin, Viola Allaj, Parvathy Manoj, Nisargbhai S. Shah, Umesh K. Bhanot, Jacklynn Egger, Juan Qiu, Elisa de Stanchina, Natasha Rekhtman, Brian Houck-Loomis, Richard P. Koche, Helena A. Yu, Triparna Sen, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 658.
DOI: https://doi.org/10.1158/1538-7445.AM2022-658
Published: 15 June 2022
View article
Journal Articles

Abstract 3594: Exportin 1 inhibition as a therapeutic strategy for small cell lung cancer

Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Fathema Uddin, Viola Allaj, Parvathy Manoj, Nisargbhai S. Shah, Umesh K. Bhanot, Juan Qiu, Elisa de Stanchina, Richard P. Koche, Triparna Sen, John T. Poirier, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3594.
DOI: https://doi.org/10.1158/1538-7445.AM2022-3594
Published: 15 June 2022
View article
Journal Articles

Abstract 3000: Ferroptosis evasion as a therapeutic strategy in STK11/KEAP1 co-mutant lung adenocarcinoma

Vidushi Durani, Corrin A. Wohlhieter, Alvaro Quintanal-Villalonga, Triparna Sen, Parvathy Manoj, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3000.
DOI: https://doi.org/10.1158/1538-7445.AM2022-3000
Published: 15 June 2022
View article
Journal Articles

Abstract 859: Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma

Emily Costa, Corrin Wohlheiter, Samuel Tischfield, Alister Funnell, JT Poirier, Álvaro Quintanal Villalonga, Triparna Sen, Charles Rudin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 859.
DOI: https://doi.org/10.1158/1538-7445.AM2022-859
Published: 15 June 2022
View article
Journal Articles

Abstract 90: STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC

Rebecca Caeser, Christopher Hulton, Emily Costa, Vidushi Durani, Megan Little, Xiaoping Chen, Sam E. Tischfield, Marina Asher, Faruk Erdem Kombak, Shweta S. Chavan, Nisargbhai S. Shah, Metamia Ciampricotti, Elisa de Stanchina, John T. Poirier, Charles M. Rudin, Triparna Sen
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 90.
DOI: https://doi.org/10.1158/1538-7445.AM2022-90
Published: 15 June 2022
View article
Journal Articles

Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Shweta S. Chavan, Fathema Uddin, Viola Allaj, Parvathy Manoj, Nisargbhai S. Shah, Joseph M. Chan, Michael Offin, Metamia Ciampricotti, Jordana Ray-Kirton, Jacklynn Egger, Umesh Bhanot, Irina Linkov, Marina Asher, Michael H. Roehrl, Juan Qiu, Elisa de Stanchina, Travis J. Hollmann, Richard P. Koche, Triparna Sen, John T. Poirier, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2022) 82 (3): 472–483.
DOI: https://doi.org/10.1158/0008-5472.CAN-21-2964
Published: 02 February 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract LB186: MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC

Rebecca Caeser, Christopher Hulton, Vidushi Durani, Emily Costa, Megan Little, Nisargbhai S. Shah, Elisa de Stanchina, John T. Poirier, Charles M. Rudin, Triparna Sen
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB186.
DOI: https://doi.org/10.1158/1538-7445.AM2021-LB186
Published: 01 July 2021
View article
Journal Articles

Abstract 1800A: STK11 and KEAP1 co-mutation cooperatively promotes rapid tumor growth in lung adenocarcinoma

Corrin A. Wohlhieter, Allison L. Richards, John T. Poirier, Fathema Uddin, Christopher Hulton, Elisa De Stanchina, Thales Papagiannakopoulos, Triparna Sen, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1800A.
DOI: https://doi.org/10.1158/1538-7445.AM2020-1800A
Published: 15 August 2020
View article
Journal Articles

Abstract 420: Rlf-Mycl1 gene fusion as a novel oncogenic driver in a mouse model of small cell lung cancer

Metamia Ciampricotti, Triantafyllia Karakousi, Alvaro Quintanal Villalonga, Viola Allaj, Andrea Ventura, Triparna Sen, JT Poirier, Thales Papagiannakopoulos, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 420.
DOI: https://doi.org/10.1158/1538-7445.AM2020-420
Published: 15 August 2020
View article
Journal Articles

The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer

Sandra Cristea, Garry L. Coles, Daniel Hornburg, Maya Gershkovitz, Julia Arand, Siqi Cao, Triparna Sen, Stuart C. Williamson, Jun W. Kim, Alexandros P. Drainas, Andrew He, Laurent Le Cam, Lauren Averett Byers, Michael P. Snyder, Kévin Contrepois, Julien Sage
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (6): 1293–1303.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-1027
Published: 13 March 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract LB-148: Combination treatment of the CHK1 inhibitor, SRA737, and low dose gemcitabine demonstrates profound synergy with anti-PDL1 inducing durable tumor regressions and modulating the immune microenvironment in small cell lung cancer

Triparna Sen, Carminia M. Della Corte, Snezana Milutinovic, Lixia Diao, Robert J. Cardnell, Ryan J. Hansen, Bryan Strouse, Michael P. Hedrick, Christian Hassig, Jing Wang, Lauren A. Byers
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-148.
DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-148
Published: 01 July 2019
View article
Journal Articles

Abstract 2822: ATR inhibitors are active as single agents and in combination with PARP1 and ATM inhibitors in molecularly distinct subsets of small cell lung cancer models

Carl M. Gay, Pan Tong, Lerong Li, C. Allison Stewart, Triparna Sen, Bonnie S. Glisson, John V. Heymach, Jing Wang, Lauren Averett Byers
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2822.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2822
Published: 01 July 2018
View article
Journal Articles

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen, Pan Tong, C. Allison Stewart, Sandra Cristea, Aly Valliani, David S. Shames, Abena B. Redwood, You Hong Fan, Lerong Li, Bonnie S. Glisson, John D. Minna, Julien Sage, Don L. Gibbons, Helen Piwnica-Worms, John V. Heymach, Jing Wang, Lauren Averett Byers
Journal: Cancer Research
Cancer Res (2017) 77 (14): 3870–3884.
DOI: https://doi.org/10.1158/0008-5472.CAN-16-3409
Published: 13 July 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 298: WEE1 inhibitor activity correlates to AXL/mTOR expression and exhibits synergy with temozolomide (TMZ) in small cell lung cancer (SCLC)

Triparna Sen, Pan Tong, Lixia Diao, You Hong-Fan, C. Allison Stewart, John V. Heymach, Jing Wang, Lauren A. Byers
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 298.
DOI: https://doi.org/10.1158/1538-7445.AM2017-298
Published: 01 July 2017
View article
Journal Articles

Abstract 3870: SLFN11 is a biomarker of sensitivity to PARP inhibition and chemotherapy in small cell lung cancer (SCLC)

C. Allison Stewart, Pan Tong, Robert Cardnell, Triparna Sen, Fatemah Mina Masrorpour, Youhong Fan, Jing Wang, Lauren Averett Byers
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3870.
DOI: https://doi.org/10.1158/1538-7445.AM2016-3870
Published: 15 July 2016
View article
Journal Articles

Abstract LB-132: Proteomic profiling identifies ATM expression level as a predictive biomarker to ATR and PARP inhibition in small cell lung cancer (SCLC)

Triparna Sen, Pan Tong, Jing Wang, Lauren A. Byers
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-132.
DOI: https://doi.org/10.1158/1538-7445.AM2016-LB-132
Published: 15 July 2016
View article
Journal Articles

Abstract 5316: Check point kinase 1 (Chk1) targeting as a novel therapeutic strategy in small cell lung cancer (SCLC)

Aly A. Valliani, Triparna Sen, Fatehmeh Masrorpour, Lixia Diao, Robert J. Cardnell, Jing Wang, Bonnie S. Glisson, Helen Piwnica-Worms, Don L. Gibbons, Lauren A. Byers
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5316.
DOI: https://doi.org/10.1158/1538-7445.AM2015-5316
Published: 01 August 2015
View article
Journal Articles

Abstract 5544: Patient-derived xenograft study reveals the pharmacology and the role of ESR1 gene aberrations in endocrine therapy resistance of ER positive breast cancer

Triparna Sen, Shunqiang Li, Jieya Shao, Robert Crowder, Robert Kitchens, Matthew J. Ellis
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5544.
DOI: https://doi.org/10.1158/1538-7445.AM2014-5544
Published: 01 October 2014
View article